David A Clump

David A Clump

University of Pittsburgh - Pittsburgh / United States
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 4701492
person_outline David A Clump's MOST POPULAR ARTICLES
1-) PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck CancerPrognostic and Predictive Impact of PD-1high T CellsBA Kansy, F Concha-Benavente, RM Srivastava, HB Jie, G Shayan, Y Lei, ...Cancer research 77 (22), 6353-6364, 20171592017
2-) ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiationFP Vendetti, P Karukonda, DA Clump, T Teo, R Lalonde, K Nugent, ...The Journal of clinical investigation 128 (9), 3926-3940, 20181282018
3-) A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of …JA Vargo, RL Ferris, J Ohr, DA Clump, KS Davis, U Duvvuri, S Kim, ...International Journal of Radiation Oncology* Biology* Physics 91 (3), 480-488, 20151242015
4-) Anaplastic thyroid cancer: prognostic factors, patterns of care, and overall survivalSM Glaser, SF Mandish, BS Gill, GK Balasubramani, DA Clump, S BeriwalHead & neck 38 (S1), E2083-E2090, 20161412016
5-) Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRTMN Theodoraki, S Yerneni, WE Gooding, J Ohr, DA Clump, JE Bauman, ...Oncoimmunology 8 (7), e1593805, 20191362019